GlassScriptPhysician profile
Azita Far
NPI 1952391542
$3,583.53
in general payments reported to CMS, 2019-2025
14 companies · $1,925 in 2025
The $1,925 reported for 2025 was more than what 81% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $729 · 2020: $250 · 2021: $72.36 · 2022: $187 · 2023: $233 · 2024: $187 · 2025: $1,925.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,925 · Food and Beverage: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,925.00 |
| Food and Beverage | $420.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $1,925.00 | 2025 | Fluid Systems - Infusion Systems, Fluid Systems - Research Devel |
| Depuy Synthes Sales INC. | $280.17 | 2019 | |
| Boston Scientific Corporation | $236.98 | 2019-2020 | |
| Vertos Medical, INC. | $150.72 | 2022 | |
| Merz North America, INC. | $144.32 | 2019 | |
| Nalu Medical, INC. | $143.45 | 2024 | Nalu Neurostimulation System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $138.93 | 2019 | |
| Amarin Pharma, INC. | $117.36 | 2023 | |
| Nevro Corp. | $115.60 | 2023 | Senza |
| Pacira Therapeutics, INC. | $108.52 | 2020 | |
| Merz Pharmaceuticals, LLC | $84.04 | 2021-2022 | |
| Allergan, INC. | $49.10 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $45.66 | 2019-2020 | |
| Spr Therapeutics, INC | $43.68 | 2024 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Azita Far listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.